Skip to main content

AI & Machine Learning in Healthcare

Philips and Radboudumc Partner to Study Atrial Fibrillation During 4Days Marches Using Wearable AI-Powered Sensor

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – July 25, 2025 – Philips and Radboud university medical center (Radboudumc) are conducting one of the first large-scale studies to explore the impact of prolonged physical activity on atrial fibrillation, leveraging wearable monitoring technology during the 4Days Marches in the Netherlands. The collaboration combines clinical expertise with cutting-edge sensor technology to better understand how exercise influences this widespread heart rhythm disorder.

Continuous Monitoring for Deeper Insight into Atrial Fibrillation

Maryland Strengthens Position as Life Sciences Powerhouse with Deep Talent Pool and Strategic Investments

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – July 25, 2025 – Maryland continues to assert itself as a national leader in life sciences, driven by a dynamic workforce, strong academic institutions, and expanding industry infrastructure. With the Washington, D.C.–Baltimore area ranking among the top six U.S. regions for R&D and manufacturing talent, the state is attracting significant investment and fostering sustainable growth across biotech and pharmaceutical sectors.

Talent-Driven Advantage for Life Sciences Expansion

Sensei and DentalMonitoring Forge Strategic Partnership to Advance AI-Driven Remote Orthodontic Care

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – July 21, 2025 – Sensei, the practice and patient management brand of Carestream Dental, has announced a strategic integration with DentalMonitoring, a global leader in AI-powered remote monitoring solutions for orthodontics. The collaboration, revealed during the 2025 American Association of Orthodontists (AAO) Annual Session in Philadelphia, marks a pivotal move in expanding digital orthodontic care with advanced clinical oversight, enhanced operational efficiency, and increased patient engagement.

Carestream Dental Showcased the Future of Dentistry at IDS 2025

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – July 21, 2025 – Carestream Dental showcased its latest innovations in clinical productivity and patient care at IDS 2025 in Cologne, Germany, under the theme “Delivering What’s Next.” The company’s presentation at Hall 11.1, C010, reflected its longstanding commitment to advancing dental technology and empowering practitioners worldwide.

Innovation That Builds on a Century of Leadership

AI-Driven Biotech Unicorns Face Tough Market as IPO Pathways Remain Uncertain

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – July 21, 2025 – The latest generation of biotech unicorns is navigating a challenging financial landscape, as AI-powered drug discovery ventures encounter tight investment conditions and a shrinking pool of exit opportunities. While their billion-dollar valuations once promised swift IPOs, today's market demands more strategic flexibility, operational discipline, and differentiated technologies.

Valuations Under Pressure in a Binary Outcome Industry

Chugai and Gero Forge Strategic AI Alliance to Tackle Age-Related Diseases

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – July 8, 2025 – In a landmark agreement that underscores the growing convergence of artificial intelligence and drug discovery, Tokyo-based Chugai Pharmaceutical has entered into a multi-phase research collaboration with Singapore-headquartered biotech Gero to target age-related diseases using AI-driven insights. The deal could exceed $1 billion in total value, positioning both companies at the forefront of longevity-focused pharmaceutical innovation.

AI-Powered Discovery for High-Impact Biologics

AI-Driven Pharmacogenetics Poised to Reshape Drug Development and Rebuild Industry Trust

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – July 8, 2025 – A confluence of artificial intelligence and genomics is creating a critical inflection point for the pharmaceutical industry—offering a long-awaited opportunity to reduce adverse drug reactions, improve clinical outcomes, and restore public trust in a sector burdened by scrutiny and skepticism.

Argenx and UNP Forge $1.5B Macrocyclic Peptide Alliance to Target ‘Undruggable’ Diseases

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – July 1, 2025 – Argenx has taken a decisive step to diversify its pipeline beyond its flagship FcRn blocker, signing a multi-target research agreement with Unnatural Products, Inc. (UNP) that could exceed $1.5 billion. The deal aims to harness UNP’s proprietary macrocyclic peptide technology to develop oral therapies for disease targets historically deemed “undruggable,” marking the largest licensing transaction to date in the macrocyclic peptide space.

Strategic Expansion Beyond FcRn Blockade

Dentsply Sirona Announces DS World Las Vegas 2025 with Strategic Focus on Connected Dentistry and Clinical Education

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – June 24, 2025 – Dentsply Sirona has officially opened registration for DS World Las Vegas 2025, its flagship clinical education event, returning to the MGM Grand from September 25–27. Designed to empower dental professionals through innovation and knowledge-sharing, the event will spotlight Dentsply Sirona’s Connected Dentistry proposition, with a strategic focus on digital integration, workflow optimization, and patient care advancement.

Driving Practice Efficiency Through Connected Technologies

Roche’s Fenebrutinib Shows Sustained Efficacy in Multiple Sclerosis Over 96 Weeks

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – June 1, 2025 – Roche has announced compelling new data from its ongoing FENopta open-label extension study, confirming that its investigational therapy fenebrutinib continues to provide sustained disease suppression in patients with relapsing multiple sclerosis (RMS) for up to two years.